CGC
Price
$1.37
Change
+$0.01 (+0.74%)
Updated
Oct 3 closing price
Capitalization
424.55M
32 days until earnings call
CRON
Price
$2.58
Change
-$0.01 (-0.39%)
Updated
Oct 3 closing price
Capitalization
992.83M
30 days until earnings call
Interact to see
Advertisement

CGC vs CRON

Header iconCGC vs CRON Comparison
Open Charts CGC vs CRONBanner chart's image
Canopy Growth
Price$1.37
Change+$0.01 (+0.74%)
Volume$19.08M
Capitalization424.55M
Cronos Group
Price$2.58
Change-$0.01 (-0.39%)
Volume$2.58M
Capitalization992.83M
CGC vs CRON Comparison Chart in %
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. CRON commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and CRON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (CGC: $1.37 vs. CRON: $2.58)
Brand notoriety: CGC: Notable vs. CRON: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CGC: 76% vs. CRON: 78%
Market capitalization -- CGC: $424.55M vs. CRON: $992.83M
CGC [@Pharmaceuticals: Generic] is valued at $424.55M. CRON’s [@Pharmaceuticals: Generic] market capitalization is $992.83M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.89B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileCRON’s FA Score has 1 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • CRON’s FA Score: 1 green, 4 red.
According to our system of comparison, CRON is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 3 TA indicator(s) are bullish while CRON’s TA Score has 3 bullish TA indicator(s).

  • CGC’s TA Score: 3 bullish, 5 bearish.
  • CRON’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CGC and CRON are a bad buy in the short-term.

Price Growth

CGC (@Pharmaceuticals: Generic) experienced а +2.24% price change this week, while CRON (@Pharmaceuticals: Generic) price change was -1.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.81%. For the same industry, the average monthly price growth was +6.75%, and the average quarterly price growth was +54.33%.

Reported Earning Dates

CGC is expected to report earnings on Nov 07, 2025.

CRON is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.81% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($993M) has a higher market cap than CGC($425M). CRON YTD gains are higher at: 27.723 vs. CGC (-50.000). CRON has higher annual earnings (EBITDA): -25.58M vs. CGC (-410.31M). CRON has more cash in the bank: 834M vs. CGC (144M). CRON has less debt than CGC: CRON (2.01M) vs CGC (328M). CGC has higher revenues than CRON: CGC (275M) vs CRON (130M).
CGCCRONCGC / CRON
Capitalization425M993M43%
EBITDA-410.31M-25.58M1,604%
Gain YTD-50.00027.723-180%
P/E RatioN/A51.80-
Revenue275M130M212%
Total Cash144M834M17%
Total Debt328M2.01M16,310%
FUNDAMENTALS RATINGS
CGC vs CRON: Fundamental Ratings
CGC
CRON
OUTLOOK RATING
1..100
7580
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9990
PRICE GROWTH RATING
1..100
5844
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (67) in the Pharmaceuticals Other industry is in the same range as CGC (92) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's SMR Rating (90) in the Pharmaceuticals Other industry is in the same range as CGC (99) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's Price Growth Rating (44) in the Pharmaceuticals Other industry is in the same range as CGC (58) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's P/E Growth Rating (6) in the Pharmaceuticals Other industry is significantly better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew significantly faster than CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCCRON
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 20 days ago
80%
Bullish Trend 12 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTRCX20.570.09
+0.44%
MFS Total Return C
BHEIX29.600.12
+0.41%
BlackRock High Equity Income K
PJVQX25.170.09
+0.36%
PGIM Jennison Value R6
YASSX11.38-0.03
-0.26%
AMG Yacktman Special Opportunities I
NWHTX36.65-0.12
-0.33%
Nationwide Bailard Tech & Sci R6

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-0.39%
SNDL - CRON
73%
Closely correlated
+1.98%
OGI - CRON
60%
Loosely correlated
+0.53%
TLRY - CRON
60%
Loosely correlated
+0.62%
CGC - CRON
57%
Loosely correlated
+0.74%
ACB - CRON
54%
Loosely correlated
-0.53%
More